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OBJECTIVES We sought to validate recently proposed risk adjustment models for in-hospital percutaneous
transluminal coronary angioplasty (PTCA) mortality on an independent data set of high risk
patients undergoing PTCA.
BACKGROUND Risk adjustment models for PTCA mortality have recently been reported, but external
validation on independent data sets and on high risk patient groups is lacking.
METHODS Between July 1, 1994 and June 1, 1996, 1,476 consecutive procedures were performed on a
high risk patient group characterized by a high incidence of cardiogenic shock (3.3%) and
acute myocardial infarction (14.3%). Predictors of in-hospital mortality were identified using
multivariate logistic regression analysis. Two external models of in-hospital mortality, one
developed by the Northern New England Cardiovascular Disease Study Group (model NNE)
and the other by the Cleveland Clinic (model CC), were compared using receiver operating
characteristic (ROC) curve analysis.
RESULTS In this patient group, an overall in-hospital mortality rate of 3.4% was observed. Multivariate
regression analysis identified risk factors for death in the hospital that were similar to the risk
factors identified by the two external models. When fitted to the data set, both external
models had an area under the ROC curve .0.85, indicating overall excellent model
discrimination, and both models were accurate in predicting mortality in different patient
subgroups. There was a trend toward a greater ability to predict mortality for model NNE as
compared with model CC, but the difference was not significant.
CONCLUSIONS Predictive models for PTCA mortality yield comparable results when applied to patient
groups other than the one on which the original model was developed. The accuracy of the
two models tested in adjusting for the relatively high mortality rate observed in this patient
group supports their application in quality assessment or quality improvement efforts. (J Am
Coll Cardiol 1999;34:692–7) © 1999 by the American College of Cardiology
The development of report cards for cardiac surgery (1–4)
has been associated with a major effort toward the develop-
ment and validation of risk adjustment models for coronary
artery bypass graft surgery (CABG) mortality (5–9). More
recently, risk adjustment models for percutaneous translu-
minal coronary angioplasty (PTCA) mortality have been
proposed and used for the comparison of the results of
different operators (10–14), but external validations on high
risk patient groups and independent data sets are lacking.
The objectives of our study were to identify risk factors for
in-hospital PTCA mortality in a tertiary care high risk
patient group, to compare and validate recently proposed
risk adjustment models for PTCA mortality in this patient
group and to assess the effect of case-mix on model
accuracy.
METHODS
Study patients. The study sample consisted of 1,476 con-
secutive percutaneous revascularization procedures per-
formed between July 1, 1994 and June 1, 1996 at the
University of Michigan Medical Center. Conventional
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PTCA was used in 1,070 procedures and new device
angioplasty (directional coronary atherectomy, coronary
stenting, rotational atherectomy and transdevice synergy)
was used in 406 procedures. Clinical and laboratory data
were obtained through a computerized data base and chart
review. Angiographic data were obtained through cine film
review. Coronary artery stenoses were classified according to
the modified American College of Cardiology/American
Heart Association classification (15).
Statistical analysis. Data are expressed as the mean
value 6 SD or as a percentage. Statistical analysis was
performed using Stata (Stata Corporation, College Station,
Texas). To assess the consistency of variable selection
between different models and different patient groups,
univariate predictors of in-hospital death were identified
using logistic regression analysis. Independent predictors of
death in the hospital were identified using stepwise multi-
variate logistic regression analysis of a model containing
univariate factors (p , 0.05). The internal model was tested
for goodness-of-fit using the Hosmer-Lemeshow statistic
(16).
Validation of external models. Predicted probabilities of
in-hospital death for individual patients were calculated
using 1) a risk adjustment logistic regression model devel-
oped at the Cleveland Clinic (17) from a multi-institutional
data base including 12,985 procedures (model CC) and 2) a
risk adjustment logistic regression model developed by the
Northern New England (NNE) Cardiovascular Disease
Study Group (18) from a multi-institutional data base
including 15,331 procedures (model NNE) (Table 1). The
predicted probabilities for the whole population and for
various subgroups were then calculated.
The NNE risk adjustment model includes the ejection
fraction (EF) as a risk factor for in-hospital death. The EF
was measured using the method of Sandler and Dodge (19).
To avoid exclusion of a small portion of the data set from
the analysis, when missing, the EF was estimated using a
multiple imputation method with inclusion of left ventric-
ular end-diastolic pressure, history of acute myocardial
infarction (AMI), history of heart failure, history of CABG,
age, gender and procedure priority (20–22). Receiver oper-
ating characteristic (ROC) curves (23) were developed using
the method of maximal likelihood estimation through the
program CLABROC developed by Metz (24). Separate
ROC curves were constructed using models CC and NNE.
Model accuracy was assessed by comparing the errors and
the areas under the ROC curves for the two external
models. The areas were compared using a univariate Z score
test statistic through the CLABROC program. Model
accuracy was further assessed by constructing calibration
curves, and goodness-of-fit was tested using the Hosmer-
Lemeshow statistic (16).
RESULTS
Baseline demographic and clinical characteristics are listed
in Table 2. There was a high percentage of patients
presenting within ,24 h of a myocardial infarction (14.5%)
and with a myocardial infarction complicated by cardiogenic
shock (3.3%). Twenty-one percent of patients had a history
of CABG, 41% had a history of PTCA and 61% had a
history of myocardial infarction.
In this high risk patient group, an overall in-hospital
mortality rate of 3.4% was observed. The highest mortality
rates were observed in patients presenting with AMI
(12.7%) and with cardiogenic shock (48%). The high
mortality rate observed in patients with AMI was a reflec-
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CABG 5 coronary artery bypass graft surgery
CC 5 Cleveland Clinic
EF 5 ejection fraction
NNE 5 Northern New England
PTCA 5 percutaneous transluminal coronary
angioplasty
ROC 5 receiver operating characteristic
Table 1. Independent Predictors of Hospital Death, Odds
Ratios and Coefficients for the Cleveland Clinic Model and the
Northern New England Model
Model CC Model NNE
Odds
Ratio Coefficient
Odds
Ratio Coefficient
Age (yr) 24.87 *3.21 log(y)
50–59 0.93 20.07
60–69 1.63 0.4881
70–79 3.32 1.198
$80 3.72 1.3147
Male gender 0.55 20.6
MI 4.75 1.56 1.85 0.6142
Shock 12.68 2.54 6.10 1.80
Emergency 7.71 2.04
Urgent 2.19 0.7853
No. of diseased vessels 1.32 0.28
Lesion complexity† 1.63 0.49
Type C lesion 1.94 0.66
EF (%)
50–59 2.53 0.9264
40–49 3.32 1.2005
,40 5.16 1.64
Preoperative IABP 3.91 1.36
Creatinine level $2 mg/dl 2.32 0.84
Any PVD 2.12 0.749
Any CHF 3.01 1.10
*Log(y) 5 log of age in years. †Type A or B1 lesion 5 1; type B2 5 2; and type C 5
3.
Any CHF 5 any history of congestive heart failure; any PVD 5 any history of
peripheral vascular disease; CC 5 Cleveland Clinic; EF 5 ejection fraction; IABP 5
intraaortic balloon pump; MI 5 myocardial infarction; NNE 5 Northern New
England.
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tion of the high percentage of patients referred for cardio-
genic shock in this group (17%). Further analysis revealed a
mortality rate of 4.7% in patients presenting with AMI not
complicated by cardiogenic shock. Multivariate analysis
identified emergency procedure, age, female gender, cardio-
genic shock, number of diseased vessels, congestive heart
failure and creatinine level .2 mg/dl as independent pre-
dictors of in-hospital mortality. The area under the ROC
curve was 0.88, indicating excellent model discrimination, and
the Hosmer-Lemeshow statistic was not significant, indicating
little departure from a perfect fit (chi-square 5 4.3; p 5 0.8).
Validation of external models. Predicted probabilities of
in-hospital death estimated using the two external models
are shown in Table 3. There was a trend for model CC to
underestimate the risk of death for each patient subgroup.
Receiver operating characteristic curve analysis revealed an
area under the ROC curve of 0.88 6 0.03 for model NNE
and an area of 0.85 6 0.03 for model CC (p 5 0.09) (Fig.
1). The overall calibration was excellent for both models,
and the Hosmer-Lemeshow statistic was not significant,
indicating little departure from a perfect fit (Fig. 2).
DISCUSSION
Predictors of death in the hospital. In this analysis, we
assessed the accuracy and potential differences of risk
adjustment models for PTCA mortality on a high risk
Figure 1. Receiver operator characteristic curves for models NNE
and CC.
Table 3. Observed and Predicted Mortality Rates in Patient Subgroups
Observed
Predicted (95% CI)
NNE Model CC Model
Total 3.4% 3.5% (3.0–3.9) 2.7% (2.3–3.2)
MI ,24 h* 12.7% 13.8% (11.2–16.4) 12% (9.7–14.5)
MI ,24 h without shock 4.7% 7.3% (5.8–8.9) 5.1% (4.3–5.8)
Cardiogenic shock 48% 39% (32–46) 37% (31–44)
Women 5.3% 4.4% (3.5–5.5) 4.2% (3.3–5.0)
Emergency 12.5% 12.5% (10.4–14.7) 8.8% (7.0–10.6)
Creatinine $2 mg/dl 11.6% 10.2% (6.4–14.0) 3.05% (1.5–4.5)
Ejection fraction ,40% 9.36% 10.6% (8.3–13.0) 5.5% (3.7–7.4)
Type C lesion 2.69% 3.3% (4.3–8.2) 4.6% (3.2–6.0)
Age (yr)
50–59 1.6% 1.3% (0.85–1.83) 1.1% (0.7–1.5)
60–69 3.2% 3.2% (2.4–4.0) 2.9% (2.1–3.6)
70–79 4.1% 5.4% (4.3–6.7) 3.9% (3.0–4.8)
$80 11.5% 11.7% (7.9–15.5) 8.7% (5.6–11.7)
*MI ,24 h 5 index procedure within 24 h of acute myocardial infarction.
CI 5 confidence interval.
Table 2. Baseline Demographic Data and Outcome
Baseline (n 5 1,476)
Age (yr) 62.9 6 11.6
Female gender 35.5%
Diabetes mellitus 27.8%
Previous MI 61%
Previous CABG 21.4%
Previous PTCA 41%
Creatinine level .2 mg/dl 4.7%
Emergency procedure 19.5%
AMI 14.5%
Cardiogenic shock 3.3%
EF ,40% 13.7%
Type B2 lesion 36%
Type C lesion 13%
Two- or three-vessel disease 55%
Outcome*
Death 3.4%
Q wave MI 0.75%
Any CABG† 0.88%
*Includes all in-laboratory and subsequent hospital outcomes. †Includes emergency,
urgent and elective CABG within the same hospital period. Data are presented as the
mean value 6 SD or percentage of patients.
AMI 5 acute myocardial infarction; CABG 5 coronary artery bypass graft
surgery; EF 5 ejection fraction; PTCA 5 percutaneous transluminal coronary
angioplasty.
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tertiary-care patient population. The mortality rate observed
in this patient group was relatively high when compared
with mortality rates previously reported in angioplasty
registries (25–27), reflecting the high percentage of patients
presenting with cardiogenic shock and AMI.
In agreement with what has been shown by other
investigators, higher mortality rates were observed in elderly
patients, in patients presenting with AMI, in women, in
patients with multivessel disease and in patients undergoing
emergency revascularization procedures (10–14). In partic-
ular, the variables identified in the internal logistic regres-
sion model as independent predictors of in-hospital death
were similar to the variables identified by the two external
models, supporting overall consistency in variable selection
across different patient groups. In addition, these variables
were identical to variables included in a list that was recently
developed from combining eight large multicenter data
bases (28), and which has been proposed as a tool for
efficient data collection to risk adjust outcomes of coronary
interventions.
Validation of the two external models. Both external
models had a high area under the ROC curve (e.g., .0.8),
indicating that they had excellent discrimination in this
high risk patient group. The area under the ROC curve of
model NNE of 0.88 observed in this study was in fact
similar to the area under the ROC curve observed in an
internal validation set of 6,037 patients during the develop-
ment of this model (area 0.88). The area under the ROC
curve for model CC was also similar to the area under the
ROC curve reported during its development (17) (area
0.84). The comparison of the two models on different
subsets of patients and on the overall patient population
suggested that the NNE model performed slightly better
than model CC in predicting mortality, although the
difference of the area under the ROC curve was not
statistically significant.
Differences in model performance. The slight difference
in model performance can be explained on the basis of
differences in variables entered in each model and their
coefficients. Age, AMI, cardiogenic shock and lesion sever-
ity were variables common to both models, whereas EF,
emergent or urgent priority, renal insufficiency, history of
congestive heart failure, history of peripheral vascular dis-
ease and intraaortic balloon pump requirement were vari-
ables present in the NNE model only. The slight difference
in model performance may also reflect baseline differences
between the cohorts from which each model was derived
and the present data set. For example, our patient group was
characterized by a high incidence of cardiogenic shock and
AMI (3% and 14%, respectively). In the data base used for
the development of model CC, the overall incidence of
AMI was 6.9% and the overall mortality rate was 1.3%. In
the data base used for the development of the NNE model,
the overall incidence of cardiogenic shock was only 0.6%
and the observed mortality rate was 1.08%. Although the
observed mortality in the group of patients with cardiogenic
shock in this study is similar to mortality rates reported by
other registry studies and in the recently completed
SHOCK (SHould we emergently revascularize Occluded
Coronaries for cardiogenic shocK?) trial (29,30), both mod-
els had a tendency to underestimate the mortality rate in this
group of patients.
Preprocedural morbidity and PTCA mortality. It is im-
portant to underscore the fact that the high mortality rate
observed in the group of patients presenting with cardio-
genic shock is more likely a reflection of the natural history
of the disease rather than a consequence of the procedure
itself. In support of this statement, the mortality rate
observed in our group of patients presenting with cardio-
genic shock was similar to the mortality rate observed in the
PTCA group of the SHOCK trial, and it was lower than
Figure 2. Observed versus predicted mortality rates by decile of
risk.
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the mortality rate observed in the medical treatment arm of
this study (30).
The issue of preprocedural morbidity becomes rather
important when trying to differentiate between “procedure-
related deaths” and “disease-related deaths.” As of today,
death after PTCA is a relatively rare event, and most of the
deaths are related to preprocedural morbidity rather than to
the procedure itself. Few deaths will be related to an
interaction between preprocedural morbidity and the pro-
cedure itself, and very few of them will be secondary to the
procedure alone. The value of risk adjustment resides in its
ability to identify and to “correct” for those comorbidities
that affect the relation between observed outcomes and the
procedure itself.
Implications of this analysis. The important finding of
this study is that despite some differences in variable
selection, the two external models performed well in pre-
dicting mortality in this patient group. In particular, both
models were rather accurate in adjusting for comorbidities
and accounting for the relatively high mortality rate ob-
served, thus adding supportive mathematic evidence to the
initial impression of a patient group at higher risk of death
in the hospital. Thus, our study shows that models that have
been developed from large multi-institutional data bases can
perform well also when applied to smaller, high risk,
single-center patient populations. This finding is particu-
larly relevant because models that are most effective in
mathematically accounting for variation in outcomes allow
physicians and institutions greater confidence that the
relation between observed outcomes and procedures is
influenced by explanatory variables related to case-mix
rather than by other unrelated variables. In addition, the
same models ensure that sheer chance is being minimized as
the explanation for changing rates of outcomes during
quality improvement efforts. Thus, for internal quality
assessment and quality improvement purposes that typically
utilize such formulas to generate expected versus observed
outcomes over a given time frame (31), institutions should
identify the model that best fits their patient group and their
data collection process.
Study limitations. A perceived potential limitation of this
analysis is that we did not validate the internal model on an
independent data set. However, the internal model was
generated only for comparison purposes and to determine
consistency of variable selection across different patient
groups, rather than to develop a new local model. Second,
both the CC model and the NNE model were validated on
a relatively small number of patients from a single center.
Therefore, we should be cautious in generalizing these
findings. Finally, although elective or bailout stenting was
available at our institution during the study period, we
cannot exclude that a more widespread use of elective
stenting could result in a further decrease in the observed
complications rates. Thus, risk adjustment models should be
viewed as a moving target, and they should be refined over
time according to further advancements in medical technol-
ogy.
Conclusions. Despite differences in variable selection, pre-
dictive models for PTCA mortality yield comparable results
when applied to patient groups other than the one on which
the original model was developed. The accuracy of the two
models tested in adjusting for the relatively high mortality
rate observed in this patient group supports their application
in quality assessment or quality improvement efforts.
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